CLSD
Clearside Biomedical Inc.
$4.07
+$0.30(+7.96%)
55
Overall
40
Value
81
Tech
44
Quality
Market Cap
$19.68M
Volume
44.10K
52W Range
$0.29 - $17.40
Target Price
$59.97
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $520.0K | $345.0K | $30.0K | $2.2M | $7.9M | $29.6M | $1.3M | $8.2M | $1.7M | ||
| Total Revenue | $520.0K | $345.0K | $30.0K | $2.2M | $7.9M | $29.6M | $1.3M | $8.2M | $1.7M | ||
| COST OF GOODS SOLD | |||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $204.0K | $355.0K | $149.0K | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $520.0K | $345.0K | $30.0K | $2.2M | $7.9M | $29.6M | $1.1M | $7.9M | $1.5M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $-25.7M | $-58.8M | $83.0M | $32.5M | $25.8M | $30.2M | $31.4M | $33.1M | $30.5M | ||
| Research & Development | $19.5M | $49.1M | $68.3M | $15.7M | $15.1M | $18.5M | $19.6M | $20.8M | $18.6M | ||
| Research Expense | $19.5M | $49.1M | $68.3M | $15.7M | $15.1M | $18.5M | $19.6M | $20.8M | $18.6M | ||
| Selling, General & Administrative | $6.3M | $9.7M | $14.7M | $16.8M | $10.8M | $11.7M | $11.8M | $11.9M | $11.8M | ||
| General & Administrative Expenses | $6.3M | $9.7M | $14.7M | $16.8M | $10.8M | $11.7M | $11.8M | $11.9M | $11.8M | ||
| Salaries & Wages | $-520.0K | $-345.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | $-83.0M | $393.0K | $247.0K | $247.0K | -- | -- | $300.0K | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-25.2M | $-58.4M | $-82.9M | $-30.3M | $-17.9M | $-627.0K | $-30.3M | $-24.8M | $-28.9M | ||
| EBITDA | $-25.8M | $-58.6M | $-84.1M | $-29.8M | $-18.0M | $554.0K | $-29.5M | $-32.4M | $-34.1M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | -- | -- | $-791.0K | $804.0K | $147.0K | -- | $3.3M | $9.4M | $9.8M | ||
| Intinc | $-684.0K | $-567.0K | $127.0K | -- | -- | -- | -- | $1.7M | $1.5M | ||
| Net Non-Operating Interest Income/Expense | $-684.0K | $-567.0K | $127.0K | $-804.0K | $-147.0K | -- | $3.3M | $1.7M | $1.5M | ||
| Other Income/Expense | -- | -- | -- | $466.0K | $275.0K | $-1.0M | $669.0K | $1.7M | $-2.8M | ||
| Other Special Charges | -- | -- | -- | $-466.0K | $-275.0K | $1.0M | $669.0K | $1.7M | $2.8M | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-25.9M | $-59.0M | $-83.6M | $-30.0M | $-18.2M | $376.0K | $-29.6M | $-32.5M | $-24.6M | ||
| Pre-Tax Income | $-25.9M | $-59.0M | $-82.8M | $-30.8M | $-18.2M | $376.0K | $-32.9M | $-23.1M | $-24.6M | ||
| NET INCOME | |||||||||||
| Net Income | $-25.9M | $-59.0M | $-82.8M | $-30.8M | $-18.2M | $376.0K | $-32.9M | $-32.5M | $-34.4M | ||
| Net Income (Continuing Operations) | $-25.9M | $-59.0M | $-82.8M | $-30.8M | $-18.2M | $376.0K | $-32.9M | $-32.5M | $-34.4M | ||
| Net Income (Discontinued Operations) | $-25.9M | $-59.0M | $-82.8M | $-30.8M | $-18.2M | $376.0K | $-32.9M | $-32.5M | $-34.4M | ||
| Net Income (Common Stockholders) | $-25.9M | $-59.0M | $-82.8M | $-30.8M | $-18.2M | $376.0K | $-32.9M | $-32.5M | $-34.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | $-24.3M | ||
| TOTALS | |||||||||||
| Total Expenses | $-25.7M | $-58.8M | $83.0M | $32.5M | $25.8M | $30.2M | $31.6M | $33.4M | $30.7M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $13.1M | $25.3M | $30.7M | $38.2M | $46.5M | $58.5M | $60.2M | $61.8M | $73.8M | ||
| Average Shares Outstanding (Diluted) | $13.1M | $25.3M | $30.7M | $38.2M | -- | $59.9M | $60.2M | $61.8M | $73.8M | ||
| Shares Outstanding | $25.3M | $31.9M | $36.0M | $44.9M | $57.4M | $60.1M | $78.5M | $74.7M | $77.1M | ||
| Basic EPS | -- | -- | -- | $-0.81 | $-0.39 | $0.01 | $-0.55 | $-0.53 | $-0.47 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-0.81 | $-0.39 | $0.01 | $-0.55 | $-0.53 | $-0.47 | ||
| Diluted EPS | $-1.97 | $-2.33 | $-2.69 | $-0.81 | $-0.39 | $0.01 | $-0.55 | $-0.53 | $-0.47 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-2.69 | -- | -- | $0.01 | $-0.55 | $-0.53 | $-0.47 | ||
| OTHER METRICS | |||||||||||
| Other Gand A | $6.3M | $9.7M | $14.7M | $16.8M | $10.8M | $11.7M | $11.8M | $11.9M | $11.8M | ||
| Rent And Landing Fees | $6.3M | $9.7M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLSD | $4.07 | +8.0% | 44.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Clearside Biomedical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW